KOD · Kodiak Sciences Inc.
$42.64
+1.39 (+3.37%)
At close · Jul 17
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our financial condition raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$2.67B
Shares
62,578,441
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$229.97M
-30.5%
FY2025
Diluted EPS
-$4.32
-29%
FY2025
Operating Cash Flow
-$136.01M
-15.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| $187.28M | $182.37M | $126.1M | $206.3M | $267.59M | $217.34M | $107.39M | $37.51M | $18.79M | |
| $47.82M | $52.02M | $60.75M | $71.02M | $73.79M | $49.71M | $28.62M | $11.68M | $7.58M | |
| $235.09M | $234.39M | $186.85M | $277.32M | $341.38M | $267.05M | $136.01M | $49.19M | $26.37M | |
| -$235.09M | -$234.39M | -$186.85M | -$277.32M | -$341.38M | -$267.05M | -$136.01M | -$49.19M | -$26.37M | |
| — | $0 | $0 | $13K | $18K | $22K | $25K | $8000 | $5.52M | |
| $4.56M | $4.52M | $11.15M | $16.73M | $7.07M | $298K | $2.9M | $1.57M | — | |
| -$128K | -$96K | -$506K | $110K | $503K | -$215K | $34K | $265K | -$4.07M | |
| — | -$229.92M | -$176.19M | $260.43M | $333.79M | -$266.92M | -$133.08M | -$47.37M | -$41.44M | |
| — | $52K | $20K | $33K | $33K | $74K | $14K | — | — | |
| -$230.66M | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M | -$133.1M | -$47.37M | -$41.44M | |
| — | — | — | — | — | — | — | — | -$41.44M | |
| — | -$229.97M | -$176.21M | -$259.18M | -$335.13M | -$267.04M | -$133.05M | -$47.36M | — | |
| USD/shares | — | -$4.32 | -$3.35 | -$4.97 | -$6.39 | — | — | — | — |
| USD/shares | — | -$4.32 | -$3.35 | -$4.97 | -$6.39 | — | — | — | — |
| shares | — | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M | 45.74M | 37.85M | 14.98M |
| shares | — | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M | 45.74M | 37.85M | 14.98M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.75×
EV/EBIT
—
Biotechnology median 26.36×
P/E (TTM)
—
Biotechnology median 7.37×